骨髓增生异常综合征患者的肾脏受累谱
该多中心回顾性研究纳入19例接受肾活检的骨髓增生异常综合征(MDS)患者,中位年龄74岁,84%表现为急性肾损伤。肾脏病理以急性小管间质性肾炎(TIN)最常见(37%),其余包括ANCA阴性寡免疫坏死性新月体性肾小球肾炎、膜性肾病等。中位随访7个月,47%患者存在慢性肾脏病3或4期,26%进展至终末期肾病。
要点
- MDS患者可出现多种自身免疫性肾脏表现,以急性TIN最为常见。
- MDS相关急性TIN的免疫荧光可显示沿肾小管基底膜和鲍曼囊的IgG沉积。
- MDS患者肾脏受累后约四分之一进展至终末期肾病,需密切监测肾功能。
核心结论
- MDS与多种自身免疫性肾脏表现相关,以急性TIN为主,应将MDS列为自身免疫性TIN的潜在病因之一。
研究设计与样本
- 回顾性多中心研究,纳入2001至2019年间瑞士和法国9个肾脏病中心接受肾活检的19例MDS患者。
主要发现
- 诊断时中位血清肌酐为2.8 mg/dL [0.6-8.3],中位尿蛋白/肌酐比为1.2 g/g [0.2-11]。
- 急性TIN见于7例(37%),1例急性TIN免疫荧光显示沿肾小管基底膜和鲍曼囊有强IgG沉积。
- 其他病理包括ANCA阴性寡免疫坏死性新月体性肾小球肾炎(3例)、膜性肾病(2例)、IgA肾病(1例)、IgA血管炎(1例)、免疫球蛋白相关膜增生性肾小球肾炎I型(1例)、新月体性C3肾小球病(1例)、纤维性肾小球肾炎(1例)和微小病变肾病(1例)。
- 中位随访7个月[1-96],9例(47%)为慢性肾脏病3期(6例)或4期(3例),5例(26%)进展至终末期肾病,3例死亡。
临床怎么用
- 对MDS患者出现急性肾损伤时应考虑肾活检以明确病理类型,尤其需警惕急性TIN。
- MDS相关肾脏受累患者中约四分之一进展至终末期肾病,应加强肾功能监测。
局限性
- 回顾性研究,样本量小(19例),随访时间异质性大。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Myelodysplastic syndromes (MDS) are characterized by a high prevalence of associated autoimmune manifestations. Kidney involvement has been rarely reported in MDS patients. We report on the spectrum of kidney pathological findings in MDS patients. METHODS: We retrospectively identified MDS patients who had undergone a kidney biopsy between 2001 and 2019 in nine Swiss and French nephrology centres. RESULTS: Nineteen patients (median age 74 years [63-83]) were included. At the time of kidney biopsy, eleven (58%) patients had extra-renal auto-immune manifestations and sixteen (84%) presented with acute kidney injury. Median serum creatinine at diagnosis was 2.8 mg/dL [0.6-8.3] and median urinary protein to creatinine ratio was 1.2 g/g [0.2-11]. Acute tubulo-interstitial nephritis (TIN) was present in seven (37%) patients. Immunofluorescence study in one patient with acute TIN disclosed intense IgG deposits along the tubular basement membrane and Bowman's capsule. Other kidney pathological features included ANCA-negative pauci-immune necrotizing and crescentic glomerulonephritis (n = 3), membranous nephropathy (n = 2), IgA nephropathy (n = 1), IgA vasculitis (n = 1), immunoglobulin-associated membrano-proliferative glomerulonephritis type I (n=1), crescentic C3 glomerulopathy (n = 1), fibrillary glomerulonephritis (n = 1) and minimal change disease (n = 1). Eleven (58%) patients received immunosuppressive treatments, among whom one developed a severe infectious complication. After a median follow-up of 7 month [1-96], nine (47%) patients had chronic kidney disease stage 3 (n = 6) or 4 (n = 3) and five (26%) progressed to end-stage kidney disease. Three patients died. CONCLUSIONS: MDS are associated to several autoimmune kidney manifestations, predominantly acute TIN. MDS are to be listed among the potential causes of autoimmune TIN.
引用
- Schwotzer N, Provot F, Ville S, et al. Spectrum of Kidney Involvement in Patients with Myelodysplastic Syndromes. Kidney Int Rep. 2021. PMID: 33732989. doi:10.1016/j.ekir.2020.12.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。